Evidence map›Paper›PMID 35663079›Full record

ArticleWorld journal of clinical cases2022

Bronchiolar adenoma with unusual presentation: Two case reports.

Ying Du, Zheng-Yan Wang, Zheng Zheng, Ying-Xue Li, Xiu-Yu Wang, Ran Du

Open access · diamondAbstract readCase Reports
In one paragraph

Article in World journal of clinical cases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ying DuDepartment of Pathology, The Affiliated Hospital of Shandong First Medical University (Liaocheng People's Hospital), Liaocheng 252000, Shandong Province, China.
Zheng-Yan WangDepartment of Pathology, The Affiliated Hospital of Shandong First Medical University (Liaocheng People's Hospital), Liaocheng 252000, Shandong Province, China.
Zheng ZhengDepartment of Pathology, The Affiliated Hospital of Shandong First Medical University (Liaocheng People's Hospital), Liaocheng 252000, Shandong Province, China.
Ying-Xue LiDepartment of Pathology, The Affiliated Hospital of Shandong First Medical University (Liaocheng People's Hospital), Liaocheng 252000, Shandong Province, China.
Xiu-Yu WangDepartment of Pathology, The Affiliated Hospital of Shandong First Medical University (Liaocheng People's Hospital), Liaocheng 252000, Shandong Province, China.
Ran DuDepartment of Pathology, The Affiliated Hospital of Shandong First Medical University (Liaocheng People's Hospital), Liaocheng 252000, Shandong Province, China. chinaduying@163.com.
Liaocheng People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe clinicopathological features, immunohistochemical characteristics, and genetic mutation profile of two unusual cases of distal bronchiolar adenoma are retrospectively analyzed and the relevant literature is reviewed. CASE SUMMARY: Case 1 was a 63-year-old female patient who had a mixed ground-glass nodule, with mild cells in morphology, visible cilia, and bilayer structures in focal areas. Immunohistochemical staining for P63 and cytokeratin (CK)5/6 revealed the lack of a continuous bilayer structure in most areas, and no mutations were found in epidermal growth factor receptor, anaplastic lymphoma kinase, ROS1, Kirsten rat sarcoma, PIK3CA, BRAF, human epidermal growth factor receptor-2 (HER2), RET, and neuroblastoma RAS genes. Case 2 was a 58-year-old female patient who presented with a solid nodule, in which most cells were observed to be medium sized, the nuclear chromatin was pale and homogeneous, local cells had atypia, and cilia were found locally. Immunohistochemical staining for P63 and CK5/6 showed no expression of these proteins in mild cell morphology whereas the heteromorphic cells showed a bilayer structure. The same nine genes as above were analyzed, and HER2 gene mutation was identified.

conclusionSome unresolved questions remain to be answered to determine whether the lesion is a benign adenoma or a part of the process of malignant transformation from benign adenoma of the bronchial epithelium. Furthermore, whether lesions with atypical bilayer structures are similar to atypical hyperplastic lesions of the breast remains to be elucidated. Moreover, clarity on whether these lesions can be called atypical bronchiolar adenoma and whether they are invasive precursor lesions is needed. Future studies should examine the diagnostic significance of HER2 gene mutation as a prognostic indicator.

Indexed as

Bronchiolar adenomaCase reportCellular atypiaCiliated muconodular papillary tumorHuman epidermal growth factor receptor-2 geneThoracic tumors

Identifiers

PMID35663079
PMCPMC9125294
OpenAlexW4229052166

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.